Posts Tagged ‘Business intelligence’

LPBI Presents at Life Sciences Collaborative

Posted in Academic Publishing, BioTechnology - Venture Creation, Curation, Evolutionary cognition, Explanatory, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Informatics, Pharmaceutical R&D Investment, Scientific & Biotech Conferences: Press Coverage, Social Development, Venture Capital, tagged Aviva Lev-Ari, Biotechnology, Biotechnology Industry Organization, Business incubator, Business intelligence, Business model, competetive intelligence, Conference Coverage with Social Media, Content Curation, curation communities, health, Larry H. Bernstein, Leaders in Pharmaceutical Intelligence, Life Sciences, pharmaceutical competitive intelligence, philadelphia, small business development, Social media on June 26, 2015| Leave a Comment »

Leaders in Pharmaceutical Intelligence Presentation at The Life Sciences Collaborative

Curator: Stephen J. Williams, Ph.D. Website Analytics: Adam Sonnenberg, BSc Leaders in Pharmaceutical Intelligence presented their ongoing efforts to develop an open-access scientific and medical publishing and curation platform to The Life Science Collaborative, an executive pharmaceutical and biopharma networking group in the Philadelphia/New Jersey area.

Our Team

For more information on the Vision, Funding Deals and Partnerships please see our site at http://pharmaceuticalintelligence.com/vision/

For more information about our Team please see our site at http://pharmaceuticalintelligence.com/contributors-biographies/

For more information of LPBI Deals and Partnerships please see our site at http://pharmaceuticalintelligence.com/joint-ventures/

For more information about our BioMed E-Series please see our site at http://pharmaceuticalintelligence.com/biomed-e-books/

E-Book Titles by LPBI

For more information on Real-Time Conference Coverage including a full list of Conferences Covered by LPBI please go to http://pharmaceuticalintelligence.com/press-coverage/

For more information on Real-Time Conference Coverage and a full listing of Conferences Covered by LPBI please go to:

http://pharmaceuticalintelligence.com/press-coverage/

The Pennsylvania (PA) and New Jersey (NJ) Biotech environment had been hit hard by the recession and loss of anchor big pharma companies however as highlighted by our interviews in “The Vibrant Philly Biotech Scene” and other news outlets, additional issues are preventing the PA/NJ area from achieving its full potential (discussions also with LSC)

Download the PowerPoint slides here: Presentationlsc

Read Full Post »

11:30AM 11/12/2014 – Personalized Medicine Coalition Award & Award Recipient Speech @10th Annual Personalized Medicine Conference at the Harvard Medical School, Boston

Posted in Academic Publishing, Conference Coverage with Social Media, Personalized and Precision Medicine & Genomic Research, Scientific & Biotech Conferences: Press Coverage, tagged @Biotech News, Affordable Care Act, biotech startup, Business intelligence, Entrepreneur, genomics, healthcare, healthcare costs, Personalized medicine, science funding, Venture capital on November 12, 2014| Leave a Comment »

11:30AM 11/12/2014 – 10th Annual Personalized Medicine Conference at the Harvard Medical School, Boston

Reporter: Aviva Lev-Ari, PhD, RN

REAL TIME Coverage of this Conference by Dr. Aviva Lev-Ari, PhD, RN – Director and Founder of LEADERS in PHARMACEUTICAL BUSINESS INTELLIGENCE, Boston http://pharmaceuticalintelligence.com

11:30 Personalized Medicine Coalition Award & Award Recipient Speech

Presentation of Personalized Medicine Coalition’s 10th Annual Award for Leadership in Personalized Medicine.

Personalized Medicine Coalition Award Recipient

Mark J. Levin
Co-Founder and Partner
Third Rock Ventures, LLC

Presenter:

Brian Munroe
PMC Founder and Senior Vice President, Government Affairs
Endo

Award in Science, Business Policy to individual to lead PM – Mark Levin

was at Ely Lilly in the 70s leading supplier of Insulin in the 20s and antibiotics in the 30s,Factor 8, pain drugs, chemotherapy
was at Genentech – Human growth Hormone and Human Insulin — both are PM, Interferon,
was at Mayfield Ventures
was at Millenium, CEO, early 90s, monoclonal antibodies
2000 discussion on the need for PMC
Founder of Foundation Medicine – molecular informatics – expands therapeutics and PM
NOW — with Third Rock Ventures, LLC

Mark Levin – award acceptance speech – Team accomplishments most important

We need to thank the patients participating in Clinical Trials

How I got involved in personalized medicine (PM): High School – Human Biology
Genetics – drive
PM – All diseases – genetic disorders — combination with extreme phenotyping, Muscular Dystrophy – splicing a gene for treatment
Drugability and PM – gene therapy, replace factor, deliver a gene to the brain and the drug. inside CSF
Gene editing – deliver to the Brain correct the gene in the Brain – therapy for ALS, Schizophrenia – understanding the genes involved in this disease, same
Cancer cure – treatment of combination therapies several at the same time vs present time treat one other emerges
cancer vaccine
Sample of blood – proteomics — in Annual Exams at MDs Annual physical
Convergent — comparison of Mutation across to 1000 patient’s mutations
Future is MOST exciting
Challenges of the Future: Biology and Technology, cells in microbiome, 10 million genes, SYSTEM BIOLOGY — will lead the way,
FUNDING SCIENCE via NIH Scientist is the most important National task
Preventative and Prognostics Medicine -need be part of DRUG development
Justification – maximize value for patient vs $$ spent – maximum value – waste and no leadership
Concern — Affordability of Healthcare to All, access to care vs economic Inequality
Leadership and Management: We truly need NATIONAL CONVERSATION — with a Leader with set of goals to solve a problem in certain time
Insurance, Pharma, HMO — budget challenge — attendees inn the room, need to provide leadership at the National Level